Alivus Life Sciences Limited
Outcome of Board Meeting
Alivus Life Sciences Limited has announced the acquisition of 76% stake in IQGEN-X Pharma Private Limited for approximately INR 9.12 crores, subject to customary adjustments.
BSE & NSE corporate filings with AI summaries
Alivus Life Sciences Limited
Alivus Life Sciences Limited has announced the acquisition of 76% stake in IQGEN-X Pharma Private Limited for approximately INR 9.12 crores, subject to customary adjustments.
Aegis Logistics Ltd
Aegis Logistics Ltd has clarified that it is in talks to acquire UAE's Tristar for $1.5 billion, but no definitive agreements have been executed and the company will make disclosures as per regulatory requirements.
Alivus Life Sciences Ltd
Alivus Life Sciences Ltd has announced the acquisition of 76% stake in IQGEN-X Pharma Private Limited for INR 9.12 crores, subject to customary adjustments. The acquisition is expected to provide a wider spectrum for the company to offer a complete end-to-end solution to its customers in both API and CDMO space.
Jolly Plastic Industries Ltd
Jolly Plastic Industries Ltd has changed its name to Sahaj Digital Ltd and altered its main object clause to include technology and digital services businesses.
Blue Blends (India) Ltd
Blue Blends (India) Ltd held a board meeting on August 18, 2026, where they approved the cancellation and extinguishment of existing equity shares held by promoters and public shareholders, and the allotment of fresh equity shares on a preferential basis.
EFC (I) Limited
EFC (I) Limited has informed the Exchange about the acquisition of Ultrafresh Modular Solutions Limited, a 51% subsidiary of TTK Prestige Limited, for 100% of its issued and paid-up capital on a fully-diluted basis.
EFC (I) Ltd
EFC (I) Ltd has announced the acquisition of Ultrafresh Modular Solutions Limited, a 51% subsidiary of TTK Prestige Limited, through a share swap mechanism. The acquisition aims to strengthen and further scale the Company's existing furniture manufacturing and Design & Built solutions business. The transaction has been done at arm's length, and the acquisition is expected to create operational and business synergies, broaden the Company's product offerings, and enhance manufacturing and distribution capabilities.
EFC (I) Limited
EFC (I) Limited has informed the Exchange regarding Outcome of Board Meeting held on August 18, 2026. The Board considered and approved the acquisition of 100% stake in Ultrafresh Modular Solutions Limited, issuance of up to 19,99,996 equity shares to the sellers, and conducting a Postal Ballot for seeking the approval of the shareholders for the proposed preferential issue of equity shares.
EFC (I) Ltd
EFC (I) Ltd has announced the acquisition of 100% stake in Ultrafresh Modular Solutions Ltd, a modular home solutions provider, for a consideration of Rs. 270 per equity share. The company will issue up to 19,99,996 equity shares to the sellers on a preferential basis, subject to shareholder and regulatory approvals.
RHI MAGNESITA INDIA LIMITED
RHI Magnesita India Limited has completed the merger of its wholly owned subsidiary, Intermetal Engineers (India) Private Limited, with Ashwath Technologies Private Limited. The Appointed Date of the Scheme is 1 April 2026. The Scheme is expected to result in operational efficiencies, rationalisation of the corporate structure, and administrative synergies, yielding benefits for the companies and their stakeholders.
Rhi Magnesita India Ltd
Rhi Magnesita India Ltd's wholly owned subsidiary Intermetal Engineers (India) Private Limited has completed its merger with Ashwath Technologies Private Limited, a wholly owned subsidiary of Intermetal, effective from 1 April 2026. The merger is expected to result in operational efficiencies and administrative synergies, yielding benefits for the companies and their stakeholders.
Jai Mata Glass Ltd
Jai Mata Glass Ltd has received recommendations from a committee of independent directors for an open offer to its shareholders by Mr. Ashwani Gulati, Ms. Kiran Gulati, and M/s Veerasha Trust. The open offer is to acquire up to 2,60,00,000 equity shares, representing 26% of the company's paid-up equity share capital, at a price of INR 1.85 per share.
Infosys Ltd
Infosys Ltd has collaborated with Knorr-Bremse AG to accelerate AI-enabled enterprise transformation. The collaboration will help Knorr-Bremse AG simplify and modernize its IT landscape, improve service quality, and accelerate its shift toward a value-driven, future-ready IT operating model.
Infosys Limited
Infosys Limited has announced a strategic collaboration with Knorr-Bremse AG to accelerate AI-enabled enterprise transformation. The collaboration will help Knorr-Bremse simplify and modernize its IT landscape, improve service quality, and accelerate its shift toward a value-driven, future-ready IT operating model.
Markolines Pavement Technologies Ltd
Markolines Pavement Technologies Ltd has received observation letters with no adverse objection from BSE Limited and National Stock Exchange of India Limited on the proposed Scheme of Amalgamation between Markolines Infra Limited and Markolines Pavement Technologies Limited.
Markolines Pavement Technologies Limited
Markolines Pavement Technologies Limited has informed the Exchange about receipt of observation letter with no adverse objection from BSE Limited and NSE Limited regarding the Scheme of Amalgamation between Markolines Infra Limited and Markolines Pavement Technologies Limited.
LG Electronics India Ltd
LG Electronics India Ltd wins 10 awards at DIGIT India's Top Appliance Awards 2026 for excellence in innovation across various categories.
Lippi Systems Ltd-$
Lippi Systems Ltd has announced the completion of its open offer to acquire up to 33,82,231 equity shares from public shareholders, representing 25.05% of the expanded share capital, at a price of ₹56.84 per share.
Piramal Pharma Limited
Piramal Pharma Limited has acquired an additional 40.67% stake in Yapan Bio Private Limited, increasing its shareholding from 33.33% to 74.00%. The acquisition was completed for an aggregate cash consideration of approximately ₹76 crores. Yapan has ceased to be an associate company and has become a subsidiary of Piramal Pharma Limited.
Piramal Pharma Ltd
Piramal Pharma Ltd has acquired an additional 40.67% stake in Yapan Bio Private Limited, increasing its shareholding to 74.00% and making Yapan a subsidiary of the company.